News for STERIS plc (STE)

Strong market leadership in infection prevention and sterilization services.Expansive product and service offerings catering to healthcare and life sciences se

Jefferies initiated coverage of Steris PLC (NYSE:STE) on May 28 with a ‘Hold’ rating and a $263 price target. The research firm reiterated that the company could come under pressure due to the risk of over 14 million Medicaid and Health Insurance individuals losing coverage. Jefferies expects STERIS to grow revenue by 8% in 2026, […]

Steris (STE) has recently been the subject of a new analyst coverage by Jefferies, a well-known financial services company. The firm has initiated its coverage

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

An analysis by Jefferies' David Windley has initiated coverage on Steris (STE), assigning it a Hold rating with a price target of $263. The company is expected

In recent developments, Morgan Stanley has adjusted its price target for Steris (STE), increasing it from a previous $240.00 to $260.00 USD. This adjustment rep

Steris PLC (STE) has recently been in the spotlight, drawing interest from investors and financial analysts due to its robust financial stance. With shares curr

Citizens JMP has adjusted its price target for Steris (STE) upwards to $280 from the previous $265, while maintaining an Outperform rating for the stock. Steris

Total Revenue Growth: 4% as reported; 6% constant currency organic growth for Q4.Gross Margin: Increased 170 basis points to 44.3% for Q4.EBIT Margin: Increase

May 15, 2025 / 01:00PM GMTOperator Good morning everyone and welcome to the STERIS plc fourth quarter 2025 conference call. (Operator Instructions) Please also

Steris plc is a Strong Buy with $281 fair value. Click for why STE, backed by growth, margin expansion & reshoring tailwinds, can overcome tariff risks.

On May 15, 2025, analyst Steven Etoch from Stephens & Co. reiterated an "Overweight" rating for Steris (STE), maintaining the price target at $250.00 USD. This

Although the revenue and EPS for Steris (STE) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

**media[626260]**

Get a deeper insight into the potential performance of Steris (STE) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

We recently published a list of the 10 Overlooked Dividend Stocks to Buy Now.

We recently published a list of the 10 Overlooked Dividend Stocks to Buy Now. In this article, we are going to take a look at where STERIS plc (NYSE:STE) stands against other overlooked dividend stocks. In recent times, dividend investing—also known as equity income—has fallen out of favor. Once a widely followed and dependable strategy, […]

Summary Steris PLC (STE), a leading global provider of infection prevention products and services, announced on April 22, 2025, that it will host a conference c

DUBLIN, IRELAND, April 22, 2025 (GLOBE NEWSWIRE) -- STERIS plc (: STE) (”œSTERIS” or the ”œCompany”) announced today that it will host a conference call